This book helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.
This book helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.
Edited by Sarah H. Wakelin, BSc, MB, BS, FRCP, Consultant Dermatologist and Honorary Seniro Lecturer, Imperial College Healthcare NHS Trust, London, UK Howard I. Maibach, MD, Professor of Dermatology, Department of Dermatology, University of California, San Francisco, USA Clive B. Archer, BSc, MBBS, MSc Med Ed, MD, PhD (Lond), FRCP, Consultant Dermatologist, St John's Institute of Dermatology, Guy's and St. Thomas' Hospitals NHS Foundation Trust, Honorary Professor of Dermatology and Immunopharmacology (UCLan) and Honorary Senior Lecturer (KCL), London, UK
